These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia. Hansen L; Jones RM; Kingdon D J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982 [TBL] [Abstract][Full Text] [Related]
5. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related]
6. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism. Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370 [TBL] [Abstract][Full Text] [Related]
7. Clinimetric evaluation of the Simpson-Angus Scale in older adults with schizophrenia. Blanchet PJ; Rompré PH J Clin Psychopharmacol; 2014 Feb; 34(1):36-9. PubMed ID: 24145218 [TBL] [Abstract][Full Text] [Related]
8. Low doses of rotigotine in patients with antipsychotic-induced parkinsonism. Di Fabio R; De Filippis S; Cafariello C; Penna L; Marianetti M; Serrao M; Pierelli F Clin Neuropharmacol; 2013; 36(5):162-5. PubMed ID: 24045607 [TBL] [Abstract][Full Text] [Related]
9. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia. Jung HY; Kim JH; Ahn YM; Kim SC; Hwang SS; Kim YS Hum Psychopharmacol; 2005 Jan; 20(1):41-5. PubMed ID: 15565639 [TBL] [Abstract][Full Text] [Related]
10. Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic. Kumsa A; Agenagnew L; Alemu B; Girma S PLoS One; 2020; 15(7):e0235365. PubMed ID: 32614868 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort. Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G; J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288 [TBL] [Abstract][Full Text] [Related]
12. Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism. Rudå D; Einarsson G; Matthiassen JB; Correll CU; Jensen KG; Klauber DG; Richard CJ; Andersen ASS; Krøigaard S; Møllegaard Jepsen JR; Fagerlund B; Winge K; Clemmesen LKH; Pagsberg AK; Paulsen RR; Fink-Jensen A Child Adolesc Ment Health; 2020 May; 25(2):79-94. PubMed ID: 32307841 [TBL] [Abstract][Full Text] [Related]
13. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism. Mateos JJ; Lomeña F; Parellada E; Font M; Fernandez E; Pavia J; Prats A; Pons F; Bernardo M Psychopharmacology (Berl); 2005 Sep; 181(2):401-6. PubMed ID: 15830229 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects. Kim JH; Byun HJ Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611 [TBL] [Abstract][Full Text] [Related]
15. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements. Brown KW; White T Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. van Harten PN; Matroos GE; Hoek HW; Kahn RS Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918 [TBL] [Abstract][Full Text] [Related]
18. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987 [TBL] [Abstract][Full Text] [Related]
19. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research. Knol W; Keijsers CJ; Jansen PA; van Marum RJ J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649 [TBL] [Abstract][Full Text] [Related]
20. [Is the glabellar reflex a component of neuroleptic-induced Parkinsonism?]. Sánchez R; Calvo JM; Jaramillo LE Biomedica; 2005 Dec; 25(4):539-46. PubMed ID: 16433181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]